`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`Aurobindo Pharma USA Inc.
`
`Petitioners,
`
`V.
`
`Andrx Labs, LLC
`
`Patent Owner(s)
`
`Case IPR2018—00530
`
`US. Patent No. 6,790,459
`
`SHIONOGI INC.’S POWER OF ATTORNEY UNDER 37 C.F.R. § 42.10
`
`
`
`IPR2018—00530
`
`U.S. Patent No. 6,790,459
`
`Shionogi Inc. (“Shionogi”), the licensee of US. Patent No. 6,790,459 by
`
`Virtue of an agreement with Patent Owner Andrx Labs, LLC, which is a subsidiary
`
`of Teva Pharmaceuticals USA Inc., hereby appoints the following attorneys and/or
`
`agents to prosecute the above captioned inter partes review and transact all
`
`business in the US. Patent and Trademark Office connected herewith:
`
`0 All practitioners at Customer Number 23483
`
`0 All practitioners at Customer Number 148630
`
`0 David A. Chavous, Reg. No. 66,047
`
`0 David A. Giordano, Reg. No. 64,480
`
`Please address all communications to:
`
`Wilmer Cutler Pickering Hale and Dorr LLP
`60 State St.
`
`Boston, MA 02109
`Telephone: 617-526-6000
`Facsimile: 617-526—5000
`
`Please address all e—mails and telephone calls to lead and back-up counsel,
`
`as identified below and in Patent Owner’s Mandatory Notices, each of whom is
`
`listed above or associated with the above Customer Number:
`
`0 Lead Counsel:
`
`David L. Cavanaugh, Reg. No. 36,476
`David.Cavanaugh@,wilmerhale.com
`Telephone: (202) 663-6025
`
`
`
`IPR2018—00530
`
`US. Patent No. 6,790,459
`
`- Back-up Counsel:
`
`Jonathan B. Roses, Reg. No. 61,115
`Jonathan.Roses@wilmerhale.com
`Telephone: (617) 526-6048
`
`David A. Chavous, Reg. No. 66,047
`dchavous
`chavousi law.com
`
`Telephone: (617) 752-2650
`
`David A. Giordano, Reg. No. 64,480
`david
`iordanolawllc.com
`
`Telephone: (617) 752—2650
`
`The individual listed below has the authority to execute this document on
`
`behalf of Shionogi.
`
`For: Shionogi Inc.
`
`4.214650va %I
`
`Name:
`
`Andrew Zoltan
`
`Title:
`
`Vice President, IP & Litigation
`
`Dated:
`
`/ F673
`
`7 0/ V
`
`